PD-1 Antibody for Reactive EBV After BMT
NCT04690036
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
PD-1
EBV Infection
Transplant
Interventions
DRUG:
toripalimab injection
Sponsor
Beijing Friendship Hospital